News
MarketBeat on MSN44m
Nektar Jumps 157% on Drug Trial Data-Can It Go Even Higher?Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback